People diagnosed with immune thrombotic thrombocytopenic purpura (TTP) in the U.S. report significant unmet healthcare needs, particularly related to…
Articles by Andrea Lobo, PhD
Taking both laboratory parameters and genetic testing into account can improve diagnostic accuracy in people with von Willebrand disease…
Children with von Willebrand disease (VWD) who undergo surgery to remove the adenoids and tonsils have a nearly sixfold…
A Chinese woman experiencing neurological symptoms who had a stroke at age 30 was ultimately diagnosed with the blood disorder hereditary…
Adding Cablivi (caplacizumab) to therapeutic plasma exchange (TPE) and corticosteroids may lead to a faster treatment response and durable…
Congenital thrombotic thrombocytopenic purpura (TTP) typically develops in infancy or early childhood, but clinicians have now reported a rare…
Expectant mothers with von Willebrand disease (VWD) are more than 12 times more likely to require a blood transfusion…
An Epstein-Barr virus (EBV) infection — prevalent and spread through bodily fluids — triggered severe immune thrombocytopenia (ITP) and…
Hetrombopag appears to be a safe and effective option for treating children with immune thrombocytopenia (ITP), with better outcomes linked to…
Following rituximab treatment, people of African ancestry with immune thrombotic thrombocytopenic purpura (iTTP) experience a relapse significantly sooner than…